22100149Cohen EE, Subramanian J, Gao F, Szeto L, Kozloff M, Faoro L, Karrison T, Salgia R, Govindan R, Vokes EEClinical lung cancerAdenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Lung NeoplasmsAdult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Bevacizumab; Carboplatin; Erlotinib Hydrochloride; Female; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Quinazolines; Survival RateTargeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trial. Clin Lung Cancer. 2012 Mar; 13(2):123-8.Clin Lung Cancer2011-11-18T00:00:002011Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trial.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000230Disorders29111600.582288AdenocarcinomaD000369Living Beings93664810.461329Aged, 80 and overD000368Living Beings1341183530.29479AgedD000328Living Beings1578255770.254454AdultD000971Procedures30624340.47627Antineoplastic Combined Chemotherapy ProtocolsD002289Disorders15810730.519185Carcinoma, Non-Small-Cell LungD008875Concepts & IdeasLiving Beings1473249570.258834Middle AgedD009367Concepts & IdeasProcedures34719320.6701Neoplasm StagingD008175Disorders32822600.404557Lung NeoplasmsD005260Physiology1992444050.191184FemaleAuthorship 468598Authorship 468585D006801Living Beings2262862810.130064HumansD008297Physiology1931408600.201635MaleD016190Chemicals & Drugs802860.908384CarboplatinD017239Chemicals & Drugs1164600.850636Paclitaxel0.4245070.1061275authors10.2522has subject areaD018287Disorders21390.970051Carcinoma, Large CellD011379Procedures74536690.561484PrognosisD011799Chemicals & Drugs652200.877248QuinazolinesD061067Chemicals & Drugs2139290.656201Antibodies, Monoclonal, HumanizedPublic Health SciencesD015996Concepts & Ideas45518560.724919Survival RateD002282Disorders14200.987059Adenocarcinoma, Bronchiolo-AlveolarD000068258732810.891448BevacizumabD00006934738900.973312Erlotinib HydrochlorideMedicineUniversity of ChicagoEzraCohenEzra Cohen41.78927490000000-87.601250000000001350Cohen, EzraASSOCIATE PROFESSOREverett E.VokesEverett E. Vokes41.78927490000000-87.601250000000001920Vokes, Everett E.ProfessorRaviSalgiaRavi Salgia41.78927490000000-87.601250000000001937Salgia, RaviEmeritus/Emerita, ProfessorTheodoreKarrisonTheodore Karrison41.78927490000000-87.601250000000002356Karrison, TheodoreResearch ProfessorMarkKozloffMark Kozloff41.78927490000000-87.6012500000000072Kozloff, MarkClinical Associate Professortrue1ASSOCIATE PROFESSORASSOCIATE PROFESSORtrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professortrue1ProfessorProfessortrue1Clinical Associate ProfessorClinical Associate Professortrue1Research ProfessorResearch ProfessorMedicine-Hem/OncAuthorship 595567Authorship 595541Authorship 5955510